Top compounds associated with response to GYPC


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.049 0.3
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.048 0.3
mRNA Mdivi-1 CTRPv2 pan-cancer AAC -0.05 0.3
mRNA BRD-K66532283 CTRPv2 pan-cancer AAC 0.046 0.3
mRNA AZD0530 FIMM pan-cancer AAC 0.28 0.3
mRNA GSK461364 CTRPv2 pan-cancer AAC -0.043 0.3
mRNA JQ-1 CTRPv2 pan-cancer AAC -0.042 0.3
mRNA RO4929097 CTRPv2 pan-cancer AAC -0.073 0.3
mRNA AA-COCF3 CTRPv2 pan-cancer AAC -0.048 0.3
mRNA BRD-K09344309 CTRPv2 pan-cancer AAC 0.097 0.3
Download CSV